Table 1.
Differences of the parameters among UI low or high subgroups
NSAIDs UI | ||||
---|---|---|---|---|
No. of the patients | Low | High | P | |
Age (y) | 0.463 | |||
< 60 | 157 | 72 | 85 | |
≥ 60 | 116 | 59 | 57 | |
Sex | 0.070 | |||
Male | 136 | 73 | 63 | |
Female | 137 | 58 | 79 | |
Type of resection | 0.001* | |||
Lobectomy | 208 | 112 | 96 | |
Segmentectomy | 65 | 19 | 46 | |
Pathology | 0.181 | |||
ADC | 252 | 117 | 135 | |
SCC | 14 | 10 | 4 | |
Others | 7 | 4 | 3 | |
Smoking status | 0.143 | |||
Never | 195 | 88 | 107 | |
Current + former | 78 | 43 | 35 | |
Alcohol status | 0.608 | |||
Never | 182 | 85 | 97 | |
Current + former | 91 | 46 | 45 | |
Comorbidity | 0.580 | |||
With | 69 | 31 | 38 | |
Without | 204 | 100 | 104 | |
T stages | 0.686 | |||
T1 + T2 | 267 | 129 | 138 | |
T3 + T4 | 6 | 2 | 4 | |
N stages | < 0.001* | |||
N0 | 241 | 106 | 135 | |
N1 + N2 | 32 | 25 | 7 | |
TNM stages | 0.004* | |||
I | 237 | 105 | 132 | |
II | 22 | 17 | 5 | |
III | 14 | 9 | 5 |
UI use intensity, NSAIDs non-steroid anti-inflammatory drugs, ADC adenocarcinoma, SCC squamous carcinoma
*With significant difference